Chemours is trading at $13.95, up 6.57%, with the broad market’s risk-on rebound the strongest available explanation.
- Major U.S. indices were sharply higher, while materials lagged, so sector strength does not explain the move.
- Recent earnings were mixed: adjusted EPS missed estimates, while adjusted EBITDA reached the high end of guidance and APM demand was strong. Coverage described only a modest initial reaction, making earnings an unclear explanation for the November 4 rally.